Nobel Biocare Q4 Profit Down 45%, Demand Slumps

ZURICH, Feb 11 (Reuters) - Swiss dental implant maker Nobel Biocare missed forecasts with a 45 percent drop in fourth-quarter net profit, as cash-strapped customers continued to cut spending on its top-of-the-range treatments.